STOP using this common medicine as it causes cancer, reveals US Research study
Shares
ISLAMABAD - STOP using common medicine ZANTAC as it causes cancer, reveals US Research study.
After the US Research study, Pakistani authorities have banned the medicine companies and agencies over producing and selling of the medicines using the similar chemical agent.
The Drug Regulatory Authority of Pakistan (DRAP) has ordered all the pharmaceutical companies to stop manufacturing medicines using ‘Ranitidine’ and to recall all such products in the market. The substance is used to treat acidity and other stomach related issues.
The notification has come days after a Swiss pharma group Novartis recalled its popular product Zantac using this raw material.
Last week, the United States’ Food and Drug Administration (US FDA) had issued a directive to ban the use of Ranitidine in drugs, fearing it could cause cancer.
It said that a nitrosamine impurity, medically called N-Nitrosodimethylamine (NDMA), had been found in some products containing Ranitidine. This is a probable carcinogenic impurity which helps the formation of cancer.
DRAP said that they are working closely with international agencies to monitor the outcome of the investigation.
